Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Antibodies against Early Proteins of Human Papillomaviruses as Diagnostic Markers for Invasive Cervical Cancer1998 · 129 citations
2. 2The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice2005 · 1,066 citations
3. 3European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection2002 · 1,896 citations
4. 4Low human papillomavirus prevalence in head and neck cancer: results from two large case–control studies in high-incidence regions2011 · 186 citations
5. 5Complex Etiology Underlies Risk and Survival in Head and Neck Cancer Human Papillomavirus, Tobacco, and Alcohol: A Case for Multifactor Disease2012 · 123 citations